Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer
[ad_1]
Amgen wins FDA nod for Lumakras as a drug combo for colorectal cancer
[ad_2]
Similar Posts
SA Charts: These companies are the biggest S&P 500 spenders on buybacks in Q3
Byadmin
[ad_1] SA Charts: These companies are the biggest S&P 500 spenders on buybacks in Q3 [ad_2]
TD Active U.S. Enhanced Dividend CAD Hedged ETF declares CAD 0.053 dividend
Byadmin
[ad_1] TD Active U.S. Enhanced Dividend CAD Hedged ETF declares CAD 0.053 dividend [ad_2]
RBC U.S. Dividend Covered Call ETF declares CAD 0.115 dividend
Byadmin
[ad_1] RBC U.S. Dividend Covered Call ETF declares CAD 0.115 dividend [ad_2]
Li-Cycle announces $15M public offering; shares tumble
Byadmin
[ad_1] Li-Cycle announces $15M public offering; shares tumble [ad_2]
Dutch Bros shows off its growth plans at the ICR Conference
Byadmin
[ad_1] Dutch Bros shows off its growth plans at the ICR Conference [ad_2]
CI Alternative Diversified Opportunities Fund ETF CAD series declares CAD 0.064 dividend
Byadmin
[ad_1] CI Alternative Diversified Opportunities Fund ETF CAD series declares CAD 0.064 dividend [ad_2]